Brief: Icosavax Granted FDA Fast Track Designation For IVX-A12

Icosavax

21/02/2023 13:37

Feb 21 (Reuters) - Icosavax Inc  ICVX.O :
    * ICOSAVAX GRANTED FDA FAST TRACK DESIGNATION FOR IVX-A12
    * ICOSAVAX GRANTED FDA FAST TRACK DESIGNATION FOR IVX-A12
    * ICOSAVAX INC - COMPANY CURRENTLY PLANS TO INITIATE A PHASE
2
TRIAL FOR IVX-A12 IN 2H 2023
    * ICOSAVAX INC - ANTICIPATES ANNOUNCING TOPLINE INTERIM
RESULTS
FROM THIS PHASE 1 TRIAL IN MID-2023

Source text for Eikon:  ID:nGNX5DtxGM 
Further company coverage:  ICVX.O 
 ((Reuters.Briefs@thomsonreuters.com;))